1 彭芝兰,魏丽惠,曹泽毅主编.子宫内膜癌.妇科常见肿瘤诊治指南(第3版),北京:人民卫生出版社,2010:43-65.
2 Jemal A,Siegel R,Ward E,et al.Cancer statistics,2007.CA Cancer J Clin,2007,57:43-66.
3 Siegel RL,Miller KD,Jemal A.Cancer statistics,2015.CA Cancer J Clin,2015,65:5-29.
4 American Cancer Society.Cancer Facts & Figures.Atlanta,GA:American Cancer Society,2015.
5 Siegel R,Ward E,Brawley O,et al.Cancer statistics,2011:The impact of eliminating socioeconomic and racial disparities on premature cancer deaths.CA Cancer J Clin,2011,61:212-236.
6 Bokhman JV.Two pathogenetic types of endometrial carcinoma.Gynecol Oncol,1983,15:10-17.
7 Hecht JL,Mutter GL.Molecular and pathologic aspects of endometrial carcinosgnesis.J Clin Oncol,2006,24:4783-4791.
8 Prat J,Gallardo A,Cuatrecasas M,et al.Endometrial carcinoma:patholo-gy and genetics.Pathology,2007,39:72-87.
9 Yeramian A,Moreno-Bueno G,Dolcet X,et al.Endometrial carcinoma:molecular alterations involved in tumor development and progression.Oncogene,2013,32:403-413.
10 Matias-Guiu X,Prat J.Molecular pathology of endometrial carcinoma.Histopathology,2013,62:111-123.
11 Liu Y,Patel L,Mills GB,et al.Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma.J Natl Cancer Inst,2014,106:dju245.
12 Iha T,Shen H,Kanazawa K.Hysterscopy to detect stage IA well differentiated endometrioid adenocarcinoma of the endometrium.Acta Obstet Gynecol Scand,2003,82:378-384.
13 Kudela M,Pilka T.Is there a real risk in patients with endometrial carcinoma undergoing diagnosic hysteroscopy (HSC)? Eur J Gyneacol Oncol,2001,22:342-344.
14 Paterlini-Brechot P,Benali NL.Circulating tumor cell (CTC) detection:clinical impact and future directions.Cancer Lett,2007,253:180-204.
15 Stott SL,Lee RJ,Nagrath S,et al.Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer.Sci Transl Med,2002,2:25ra23.
16 Liu JF,Kindelberger D,Doyle C,et al.Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients.Gynecol Oncol,2013,131:352-356.
17 Obermayr E,Castillo-Tong DC,Pils D,et al.Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance—a study of the OVCAD consortium.Gynecol Oncol,2013,128:15–21.
18 Pils D,Tong D,Hager G,et al.A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer—a study of the OVCAD consortium.BMC Cancer,2013,13:178.
19 Rhim AD,Mirek ET,Aiello NM,et al.EMT and dissemination precede pancreatic tumor formation.Cell,2012,148:349-361.
20 Chaffer CL,Weinberg RA.A perspective on cancer cell metastasis.Science,331:1559-1564.
21 Bogani G,Liu MC,Dowdy SC.Detection of circulating tumor cells in high-risk endometrial cancer.Anticancer Res,2015,35:683-687.
22 Ji XQ,Sato H,Tanaka H,et al.Real-time quantitative RT-PCR detection of disseminated endometrial tumor cells in peripheral blood and lymph nodes using the LightCycler System.Gynecol Oncol,2006,100:355-360.
23 Klein A,Fishman A,Zemer R,et al.Detection of tumor circulating cells by cytokeratin 20 in the blood of patients with endometrial carcimona.Gynecol Oncol,2000,78:352-355.
24 Amant F,Moerman P,Neven P,et al.Endometrial cancer.Lancet,2005,366:491-505.
25 NCCN clinical practice guidelines in oncology (NCCN Guidelines),Uterine Neoplasms,Version I,2017.
26 彭鸿灵,赵霞.2015年NCCN子宫内膜癌临床实践指南解读.中国医师杂志,2015,17:1144-1146.
27 FIGO Committee on Gynecologic Oncology.FIGO staging for carcinoma of the vulva,cervix,and corpus uteri.Int J Gynecol Obstet,2014,125:97-98.
28 Koh WJ,Greer BE,Abu-Rustum NR,et al.Uterine neoplasms,version 1.2014.J Natl Compr Canc Netw,2014,12:248-280.
29 张燕燕,李群.晚期子宫内膜癌的治疗进展.实用癌症杂志,2013,8:327-329.
30 Humber CE,Tierney JF,Symonds RP,et al.Chemotherapy fr advanced,recurrent or metastatic endometrial cancer:a systematic review of Cochrane collaboration.Ann Oncol,2007,18:409-420.
31 Bruner DW,Barsevick A,Tian C,et al.Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma:a Gynecologic Oncology Group study.Qual Life Res,2007,16:89-100.
32 Setiawan VW,Yang HP,Pike MC,et al.Type I and II endometrial cancers:have they different risk factors? J Clin Oncol,2013,31:2607-2618.